Cash & equivalents increased 74.7%
Cash & equivalents changed +74.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +74.7% from the comparable as-filed period.
Gross margin changed +285 basis points from the comparable as-filed period.
Operating income changed -33.8% from the comparable as-filed period.
Operating margin changed -2064 basis points from the comparable as-filed period.
Research & development changed -20.0% from the comparable as-filed period.
Gross profit changed +5.2% from the comparable as-filed period.
Inventory changed +10.5% from the comparable as-filed period.
Net income changed -10.8% from the comparable as-filed period.
Revenue changed +1.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.